Access Bio, Inc. (KOSDAQ:950130)
South Korea · Delayed Price · Currency is KRW 2,870.00
+90.00 (3.24%)
Apr 1, 2026, 3:30 PM KST
Access Bio Market Cap
Access Bio has a market cap or net worth of 100.95 billion as of April 1, 2026. Its market cap has decreased by -50.69% in one year.
Market Cap
100.95B
Enterprise Value
-249.91B
Revenue
54.67B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,870.00
Market Cap Chart
Since May 30, 2013, Access Bio's market cap has decreased from 269.10B to 100.95B, a decrease of -62.49%. That is a compound annual growth rate of -7.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2026 | 97.78B | -26.84% |
| Dec 30, 2025 | 133.66B | -26.78% |
| Dec 30, 2024 | 182.55B | -39.72% |
| Dec 28, 2023 | 302.84B | -26.91% |
| Dec 29, 2022 | 414.36B | -27.26% |
| Dec 30, 2021 | 569.63B | -27.38% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 69.62T |
| Celltrion | 43.13T |
| Sam Chun Dang Pharm. | 19.28T |
| ALTEOGEN | 18.27T |
| DK Life Science | 108.75B |
| CKD Bio | 102.86B |
| P&S Robotics | 99.28B |
| Kukje Pharma | 97.43B |